EUVIMEDEUVIMED entdecken
Crossref

The superiority of immune-inflammation summary index for diagnosing periprosthetic joint infection

Zhuo Li, Zulipikaer Maimaiti, Jun Fu, Zhi-Yuan Li, Li-Bo Hao, Chi Xu, Ji-Ying Chen

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Zhuo Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, People's Republic of China; Department of Orthopedics, The First Medical Center, Chinese PLA General …. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Hip, Arthritis, Infectious. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Accurate and rapid diagnosis of periprosthetic joint infections (PJI) is particularly challenging. This study aimed to evaluate the diagnostic value of a newly developed immune-inflammation summary index (IISI) for PJI. METHODS: Our study enrolled 171 aseptic loosening (AL) and 172 PJI cases. Based on a biological-driven approach, the IISI was formulated as C-reaction protein (CRP) × globulin × neutrophil / [lymphocyte × albumin]. Receiver operating characteristic (ROC) curves were constructed to compare the diagnostic performance of IISI with other known serum markers. Subgroup analysis was also performed to explore the robustness of IISI. Restricted cubic splines were used to evaluate the dose-response association. Additionally, changes in IISI levels prior to reimplantation were investigated. RESULTS: The levels of all tested biomarkers were significantly different between the PJI and AL groups (all P < 0.05). ROC analysis revealed that IISI outperformed any other marker in diagnosing PJI with an area under the curve (AUC) value of 0.890. The diagnostic performance of IISI was also optimal in the hip (0.898), knee (0.903), low-grade infection (0.841), and culture-negative (0.919) subgroups. The optimal cut-off value is stabilized at around 1.6. The nonlinear association between IISI scores and PJI was also confirmed (P < 0.001). The levels of IISI before reimplantation demonstrated a significant decrease (P < 0.001) and were comparable to those of the AL group (P = 0.143). CONCLUSION: IISI can improve the utilization of serum indicators and is superior to other well-known biomarkers in diagnosing PJI. Further studies should evaluate its specific role in different infectious and inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, HipArthritis, InfectiousHumansInflammationC-Reactive ProteinBiomarkersSynovial FluidSensitivity and SpecificityBlood SedimentationRetrospective Studies

Stichwörter der Autor:innen

Diagnostic biomarkerImmune-inflammation summary indexImmune-inflammatory statusPeriprosthetic joint infection

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • School of Medicine, Nankai University, Tianjin, People's Republic of China; Department of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Department of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Department of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China; Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, People…
  • School of Medicine, Nankai University, Tianjin, People's Republic of China; Department of Orthopedics, The First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China; Department of Orthopedi…

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, Z., Maimaiti, Z., Fu, J., Li, Z. Y., Hao, L. B., Xu, C., & Chen, J. Y. (2023). The superiority of immune-inflammation summary index for diagnosing periprosthetic joint infection. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110073

Vancouver

Li Z, Maimaiti Z, Fu J, Li ZY, Hao LB, Xu C, et al. The superiority of immune-inflammation summary index for diagnosing periprosthetic joint infection. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110073

BibTeX
@article{Li2023,
  author = {Li, Zhuo and Maimaiti, Zulipikaer and Fu, Jun and Li, Zhi-Yuan and Hao, Li-Bo and Xu, Chi and Chen, Ji-Ying},
  title = {The superiority of immune-inflammation summary index for diagnosing periprosthetic joint infection},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110073}
}
Kostenlos starten →